siROR1 treatment also significantly reduced CAV1 in A431 (vulval epidermoid carcinoma) and HeLa (cervical cancer) cell lines, indicating the involvement of ROR1 in other types of cancer cells (Supplementary Fig. 3b). This evidence concerns the gene CAV1 and cervical carcinoma.